Log In
Print this Print this

MCAF5352A, NI-1401, RG7624

  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionHuman mAb that binds to two forms (IL-17A and IL-17F) of the human IL-17 family of cytokines
Molecular Target Interleukin-17A (IL-17A) ; Interleukin-17F (IL-17F)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation
Partner Genentech Inc.; Roche

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today